Stay updated on Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial page.

Latest updates to the Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial page
- Check7 days agoChange DetectedUpdates to the study record dates (Last Update Posted and Study Completion) and removal of non-critical related-topic tags such as 'Multiple myeloma' and 'MedlinePlus Genetics'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check14 days agoChange DetectedAdded related topics 'Multiple myeloma' and 'MedlinePlus Genetics' and updated the page revision from v3.3.1 to v3.3.2.SummaryDifference0.1%

- Check21 days agoChange DetectedPublication notes were updated to state that PubMed-listed publications are auto-filled and may not pertain to the study, and the revision version updated to v3.3.1.SummaryDifference0.1%

- Check29 days agoChange DetectedThe record now lists new update dates (2025-11-06, 2025-11-10, 2025-11, 2026-01-31) and the funding-status notice about lapse in government funding was removed.SummaryDifference0.3%

- Check36 days agoChange DetectedThe 'Multiple Myeloma' condition label and the related 'MedlinePlus Genetics' topics are removed from the page.SummaryDifference0.1%

- Check43 days agoChange DetectedAdded related topics 'Multiple myeloma' and 'MedlinePlus Genetics' under Related Topics; no deletions were made. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial page.